Alzheimer Disease
Conditions
Brief summary
The purpose of this study is to investigate how we can detect Alzheimer's disease early by using an online memory test and a simple blood test. These new methods for early diagnosis could allow people to begin treatment sooner, with the potential to improve the lives of millions of people.
Interventions
OTHERCognitive Assessment
Montreal Cognitive Assessment - MoCA, which is a cognitive screening tool that assesses: memory, concentration, language, and orientation to time and place. this written cognitive test should take no more than 20 minutes.
Sponsors
AdventHealth Translational Research Institute
Davos Alzheimer's Collaborative
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Subjects must meet the following criteria for entry into the study: 1. Male or female \> 65 years of age at the time of consent; 2. Understand and voluntarily sign an informed consent form; Inclusion criteria is assessed at both e-consent (assessed by participant's self-reporting of age and understanding) and in-person consent at TRI (assessed by clinical research coordinators in TRI).
Exclusion criteria
Subjects who meet any of the following criteria will not be eligible for entry into the study: 1. Subjects who are unable to hear and see well enough to complete the assessments; 2. Prior diagnosis of dementia or Alzheimer's disease documented in their medical record and/or as diagnosed by a physician;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantify the proportion of individuals at least 65 years old with cognitive impairment | Less than 6 months |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORSteven Smith, MD
Study PI
Outcome results
None listed